NIH Funding Opportunities (Notices, PA, RFA)

Funding Opportunity PAR-25-378 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions and 4) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Concurrently, NA populations experience unique sociopolitical, historical, and environmental stressors and risks that may exacerbate health conditions and/or impact the effectiveness of existing solutions to address the conditions. They also possess unique strengths and resiliencies that can mitigate stressors or inform intervention strategies. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to test science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment. Interventions should be designed with a consideration for sustainability within the communities where they are tested, and have the flexibility to be readily adapted, disseminated, and scaled up to other communities where culturally appropriate. For the purposes of this NOFO, NA includes the following populations: Alaska Natives, American Indians (whose ancestral lands fall at least partially within the U.S. main land).

Categories: Job Watch, Literature Watch

Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025

Wed, 2025-01-22 10:38

Notice NOT-HS-25-015 from the NIH Guide for Grants and Contracts

Categories: Job Watch, Literature Watch

Notice of Informational Webinar for RFA-EY-25-002 Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)

Wed, 2025-01-22 10:30

Notice NOT-EY-25-006 from the NIH Guide for Grants and Contracts

Categories: Job Watch, Literature Watch

Anil Jegga

NIH Funding Opportunities (Notices, PA, RFA)

Notice of Early Expiration of RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)"

Notice of Early Termination of NOT-OD-24-117 "Notice of Information: Research Opportunities Centering the Health of Women Across the HIV Research Continuum"

Notice of Information to Revise the Scheduling Details for PA-25-212 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)"

Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025

NIH Operates Under a Continuing Resolution

Notice to Extend the Expiration Date of PAR-23-220 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)

Notice to Extend the Expiration Date of PAR-23-219 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)

Implementation Update: Enhancing Security Measures for NIH Controlled-Access Data

Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

Protecting Human Genomic Data when Developing Generative Artificial Intelligence Tools and Applications

Rescission of the Final Scientific Integrity Policy of the National Institutes of Health

Implementation Update: Delayed Effective Date for the NIH Intramural Research Program Access Planning Policy

Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025

Notice of Informational Webinar for RFA-EY-25-002 Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)

Pages